Article Details
Retrieved on: 2022-09-17 12:11:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Swissmedic has issued a temporary marketing authorisation for AstraZeneca's drug Evusheld for the prevention of Covid-19 in high-risk people.
Article found on: www.swissinfo.ch
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here